As patents on weight-loss drugs expire, doctors and patients hotly anticipate cheaper generics

Now that patents have expired, generic versions of Novo Nordisk's blockbuster weight-loss drugs could arrive in Canada within months, according to experts. Doctors say these cheaper versions will improve access and could also change societal perceptions around weight loss and reduce the cost and burden on the health-care system.